Table of Contents 1. Research Methodology 2. Executive Summary 3. Strategic Recommendations 4. Hepatitis B Treatment Market: Product Outlook 5. Global Hepatitis B Treatment Market: Growth and Forecast 5.1. Global Hepatitis B Treatment Market, By Value (2012-2016) 5.2. Global Hepatitis B Treatment Market, By Value (2017-2022) 5.3. Global Hepatitis B Treatment Market - By Type, By Value 5.3.1. Global Hepatitis B Treatment Market, By Value, % (2016) 5.3.2. Global Hepatitis B Treatment Market, By Value, % (Forecast 2022F) 5.4. Global Hepatitis B Treatment Market, By Type, By Value (2012-2022) 5.4.1. Therapeutics, By Value (2012-2022) 5.4.2. Vaccines, By Value (2012-2022) 5.5. Global Hepatitis B Treatment Market, By End-User, By Value (2012-2022) 5.5.1. Male, By Value (2012-2022) 5.5.2. Female, By Value (2012-2022) 6. North America Hepatitis B Treatment Market: Growth and Forecast 6.1. North America Hepatitis B Treatment Market, By Value (2012-2016) 6.2. North America Hepatitis B Treatment Market, By Value (2017-2022) 6.3. North America Hepatitis B Treatment Market - By Type, By Value 6.3.1. North America Hepatitis B Treatment Market, By Value, % (2016) 6.3.2. North America Hepatitis B Treatment Market, By Value, % (Forecast 2022F) 6.4. North America Hepatitis B Treatment Market, By Type, By Value (2012-2022) 6.4.1. Therapeutics, By Value (2012-2022) 6.4.2. Vaccines, By Value (2012-2022) 6.5. North America Hepatitis B Treatment Market, By End-User, By Value (2012-2022) 6.5.1. Male, By Value (2012-2022) 6.5.2. Female, By Value (2012-2022) 6.6. North America Hepatitis B Treatment Market: Country Analysis (U.S., Canada) 6.6.1. North America Hepatitis B Treatment Market, Country Share, 2016 (% of Total) 6.6.2. North America Hepatitis B Treatment Market, Country Share, 2022 (% of Total) 6.7. U.S. Hepatitis B Treatment Market: Growth and Forecast 6.7.1. U.S. Hepatitis B Treatment Market, By Value (2012-2016) 6.7.2. U.S. Hepatitis B Treatment Market, By Value (2017-2022) 6.8. U.S. Hepatitis B Treatment Market - By Type, By Value 6.8.1. Therapeutics, By Value (2012-2022) 6.8.2. Vaccines, By Value (2012-2022) 6.9. U.S. Hepatitis B Treatment Market - By End-User, By Value 6.9.1. Male, By Value (2012-2022) 6.9.2. Female, By Value (2012-2022) 6.10. Canada Hepatitis B Treatment Market: Growth and Forecast 6.10.1. Canada Hepatitis B Treatment Market, By Value (2012-2016) 6.10.2. Canada Hepatitis B Treatment Market, By Value (2017-2022) 6.11. Canada Hepatitis B Treatment Market - By Type, By Value 6.11.1. Therapeutics, By Value (2012-2022) 6.11.2. Vaccines, By Value (2012-2022) 6.12. Canada Hepatitis B Treatment Market - By End-User, By Value 6.12.1. Male, By Value (2012-2022) 6.12.2. Female, By Value (2012-2022) 7. Europe Hepatitis B Treatment Market: Growth and Forecast 7.1. Europe Hepatitis B Treatment Market, By Value (2012-2016) 7.2. Europe Hepatitis B Treatment Market, By Value (2017-2022) 7.3. Europe Hepatitis B Treatment Market - By Type, By Value

List of Figures Figure 1: Global Hepatitis B Treatment Market Size, By Value, 2012-2016 (USD Million) Figure 2: Number of patients with Hepatitis B Virus (HBsAg) infection by WHO region, 2015 (In Million) Figure 3: Global Healthcare Expenditure, 2012-2016 (In Trillion) Figure 4: Global Hepatitis B Treatment Market Size, By Value, 2017-2022 (USD Million) Figure 5: Global Hepatitis B Treatment Market Size, By Type, 2016 (%) Figure 6: Global Hepatitis B Treatment Market Size, By Type, 2022 (%) Figure 7: Global Hepatitis B Treatment Market- By Type, By Value 2012-2022 (USD Million) Figure 8: Global Hepatitis B Treatment Market- By End-User, By Value 2012-2022 (USD Million) Figure 9: Global Sales of HBV approved Drugs, By Value, 2014-2016 (USD Million) Figure 10: Global Sales of Viread, By Value, 2015-2016 (USD Million) Figure 11: Global Hepatitis B Treatment Market Size, By Region, 2016 (%) Figure 12: Global Hepatitis B Treatment Market Size, By Region, 2022 (%) Figure 13: North America Hepatitis B Treatment Market Size, By Value, 2012-2022 (USD Million) Figure 14: North America GDP, 2012-2015 (USD Trillion) Figure 15: North America GDP, By Select Country, 2016 (USD Trillion) Figure 16: Population aged 65 & above, 2012-2016 (% of total) Figure 17: North America Hepatitis B Treatment Market Size, By Type, 2016 (%) Figure 18: North America Hepatitis B Treatment Market Size, By Type, 2022 (%) Figure 19: North America Hepatitis B Treatment Market- By Type, By Value 2012-2022 (USD Million) Figure 20: North America Hepatitis B Treatment Market- By End-User, By Value 2012-2022 (USD Million) Figure 21: North America Hepatitis B Treatment Market, Country Share, 2016 (% of Total) Figure 22: North America Hepatitis B Treatment Market, Country Share, 2022 (% of Total) Figure 23: U.S. Hepatitis B Treatment Market Size, By Value, 2012-2022 (USD Million) Figure 24: U.S. Per Capita Healthcare Expenditure, 2012-2016 (In USD) Figure 25: Reported acute (new) cases of Hepatitis B Virus in U.S., (2012-2015) Figure 26: Incidences rate of acute Hepatitis B in U.S., By sex (2012-2015) Figure 27: Incidence of acute Hepatitis B in U.S., By age group, (2012-2015) Figure 28: U.S. Hepatitis B Treatment Market- By Type, By Value 2012-2022 (USD Million) Figure 29: U.S. Hepatitis B Treatment Market- By End-User, By Value 2012-2022 (USD Million) Figure 30: Market Share of HBV approved Drugs in U.S., 2016 (% Share) Figure 31: Canada Hepatitis B Treatment Market Size, By Value, 2012-2022 (USD Million) Figure 32: Canada Per Capita Healthcare Expenditure, 2012-2016 (In USD) Figure 33: Canada Life Expectancy at birth rate (Years), 2012-2015 Figure 34: Prevalence of Hepatitis B in Canada, (Patients per 100,000 (2012-2016) Figure 35: Number of Hepatitis B Patients, Canada, (2013-2016) Figure 36: Prevalence of Hepatitis B among Male population, Canada, (Patients per 100,000) (2012-2016) Figure 37: Prevalence of Hepatitis B among Female population, Canada, (Patients per 100,000) (2012-201